Siemens and JEOL Sign New Strategic Partnership to Co-Develop Advanced Clinical Chemistry Platforms

Agreement aims to deliver industry-leading analyzers for the global clinical laboratory market

Tarrytown, NY and Tokyo, Japan, July 28, 2011 – Siemens Healthcare Diagnostics and JEOL have signed a new strategic partnership for the design, manufacture and distribution of new advanced clinical chemistry platforms for the global clinical laboratory market, which experienced an estimated 5% growth in 2010 and is expected to climb in the future.1 This 10-year agreement also extends an existing Siemens-JEOL relationship targeted at enhancing current systems within Siemens’ clinical chemistry portfolio. Both aspects of the partnership help ensure that mid- to high-volume laboratories – a large segment of the in vitro diagnostics testing industry – can continue accessing innovative technologies that support gains in efficiency, reliability and accuracy.

The evolving needs of laboratories worldwide are requiring clinical chemistry analyzers to deliver better workstation consolidation that minimizes costs, optimizes productivity and provides access to an expanding test menu. For mid- to high-volume laboratories in particular, they must also be able to fluidly manage peak workload requirements and consistently meet high turnaround-time benchmarks. Recognizing the increased demands the current laboratory environment is placing on these tools, Siemens and JEOL will focus on meeting these needs by developing new clinical chemistry platforms based on Siemens’ history of proven innovation coupled with JEOL’s next-generation micro volume technology. This partnership will also be leveraged to further streamline and enhance Siemens’ ADVIA® line of clinical chemistry analyzers, all aimed at helping laboratories further reduce costs while improving workflow and uptime.

“Delivering solutions that ensure laboratories meet their clinical chemistry testing needs remains a core business focus for Siemens and helps our customers achieve both their clinical and business goals,” said Dave Hickey, CEO, Chemistry/Immunoassay, Automation, and Diagnostics IT Business Unit, Siemens Healthcare Diagnostics. “Through this expanded partnership with JEOL we can harness our collective strengths in innovation and focus on delivering best-in-class systems to the market.”

“We are pleased to continue our long-standing relationship with Siemens Healthcare Diagnostics,” said Gon-Emon Kurihara, President of JEOL. “Our new partnership combines the strengths of two leading diagnostic companies whose joint expertise offers best-in-class solutions for the laboratory, and we look forward to expanding the clinical utility of these solutions cooperatively."

1. http://www.aacc.org/publications/cln/2011/ExpoIssue/Pages/RecordBreaking2011ClinicalLab.aspx. Accessed 7/26/11.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2010 (to September 30), the Sector posted revenue of 12.4 billion euros and profit of around 750 million euros. For further information please visit: www.siemens.com/healthcare.

JEOL is a leading global supplier of scientific instruments used for research and development in the fields of nanotechnology, life sciences, optical communication, forensics, and biotechnology. Utilizing its unique technologies, products, services, and knowledge, JEOL helps its customers make significant breakthroughs in product development and scientific research. JEOL products include scientific instrumentation and industrial equipment, based on five major product groups. As part of the company’s contribution to the life sciences, JEOL offers state of the art medical devices designed for development of advanced drugs and medical technology. The customer support programs insure continuous, stable operation of equipment at optimum capacity for the benefit of medical personnel and patients. JEOL medical equipment products include clinical biochemistry analyzers, laboratory information systems, amino acid analyzers, and laboratory automation systems.

Contact: Gian Sachdev
mailto: [email protected].
610-448-3024

More News